FLUORINE-CONTAINING GRAFT COPOLYMER, AND PREPARATION METHOD AND USE THEREOF
20230312795 · 2023-10-05
Inventors
- Lifen ZHANG (Suzhou, CN)
- Jiannan CHENG (Suzhou, CN)
- Zhenping CHENG (Suzhou, CN)
- Jinying WANG (Suzhou, CN)
- Xiulin Zhu (Suzhou, CN)
Cpc classification
C07D249/04
CHEMISTRY; METALLURGY
Y02E60/50
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
International classification
Abstract
The invention provides a fluorine-containing graft copolymer, and a preparation method and use thereof. The method includes the following steps: under a protective atmosphere, reacting a compound of Formula (I) and a compound of Formula (II) in a first organic solvent in the presence of a catalyst and a ligand at 20-30° C., to obtain the fluorine-containing graft copolymers of Formula (III) after complete reaction. The compounds of Formulas (I) and (II), and the fluorine-containing graft copolymer of Formula (III) have a structural formula shown below:
##STR00001##
##STR00002##
##STR00003##
and the compound of Formula (II) comprises a polyethylene glycol segment and a terminal alkynyl group, wherein a=4-8; b=6-8; n=1-20; and m=3-22. In the present invention, a graft copolymer of a main-chain-type “semi-fluorinated” alternating copolymer is obtained for the first time by post-polymerization modification using a reactive functional group contained in the main-chain-type “semi-fluorinated” alternating copolymers.
Claims
1. A method for preparing a fluorine-containing graft copolymer, comprising steps of: under a protective atmosphere, reacting a compound of Formula (I) and a compound of Formula (II) in a first organic solvent in the presence of a catalyst and a ligand at 20-30° C., to obtain the fluorine-containing graft copolymer of Formula (III), wherein the compounds of Formulas (I) and (II), and the fluorine-containing graft copolymers of Formula (III) have a structural formula shown below: ##STR00012## ##STR00013## ##STR00014## wherein a=4-8; b=6-8; n=1-20; and m=3-22.
2. The preparation method according to claim 1, wherein the compound of Formula (I) is prepared by a process comprising: under a protective atmosphere, reacting a compound of Formula (A) with an azide in a second organic solvent, in the presence of a phase catalyst at 50-55° C., to obtain the compound of Formula (I), wherein the compound of Formula (A) has a structural formula of: ##STR00015## wherein a=4-8; b=6-8; and n=1-20.
3. The preparation method according to claim 2, wherein the phase catalyst comprises a crown ether compound; and the second organic solvent is selected from the group consisting of chloroform, N, N-dimethyl formamide, dimethyl sulfoxide and any combination thereof.
4. The preparation method according to claim 2, wherein the molar ratio of the compound of Formula (A) to the azide is 1: 1-1:40; and the molar ratio of the compound of Formula (A) to the phase catalyst is 1: 2-1:80.
5. The preparation method according to claim 1, wherein the molar ratio of the compound of Formula (I) to the compound of Formula (II) is 1:20-1:80.
6. The preparation method according to claim 1, wherein the catalyst is selected from the group consisting of cuprous bromide, cuprous chloride, cupric sulfate pentahydrate and any combination thereof; and the ligand comprises pentamethyl diethylenetriamine and/or ascorbic acid.
7. The preparation method according to claim 1, wherein the molar ratio of the compound of Formula (I) to the catalyst is 1:1-1:4; and the molar ratio of the compound of Formula (I) to the ligand is 1:2-1:20.
8. The preparation method according to claim 1, wherein the first organic solvent is selected from the group consisting of toluene, N, N-dimethyl formamide, and tetrahydrofuran and any combination thereof.
9. A fluorine-containing graft copolymer prepared by the method according to claim 1, wherein the fluorine-containing graft copolymer comprises a lipophilic chain having a fluorine-containing segment and a hydrophilic chain having a polyethylene glycol segment, the polyethylene glycol segment is a side chain; and the fluorine-containing graft copolymer has a structural formula (III): ##STR00016## wherein a=4-8; b=6-8; n=1-20; and m=3-22.
10. Use of the fluorine-containing graft copolymer according to claim 9 in the preparation of a surfactant.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0033] The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0044] The specific embodiments of the present invention will be described in further detail by way of examples. The following examples are intended to illustrate the present invention, instead of limiting the scope of the present invention.
[0045] In the examples of the present invention, only the catalyst cuprous bromide and the ligand pentamethyl diethylene triamine need to be refined before use, and all other chemical reagents are commercially available and used directly.
[0046] In the examples of the present invention, the characterization conditions of the product are as follows:
[0047] .sup.1H NMR and .sup.19F NMR are performed on INOVA 600 MHz nuclear magnetic spectrometer, where the solvent is CDCl.sub.3, and the internal standard is TMS.
[0048] Preparation of test samples for .sup.1H NMR and .sup.19F NMR: About 15 mg of the sample is weighed, fed to an NMR tube, and added with 0.6 mL of CDCl.sub.3.
[0049] Molecular weight (M.sub.n) and polydispersity index (PDI): Waters 1515 Gel Permeation chromatograph (GPC), mobile phase tetrahydrofuran (THF), and column temperature: 30° C.
[0050] Preparation of test samples for GPC: About 10 mg of the sample is weighed, dissolved in 3-4 mL of THF, filtered through a syringe filter after thorough dissolution, and added to a sample vial.
[0051] The ultraviolet-visible (UV-vis) absorption spectra are measured on Shimadzu UV-2600 spectrophotometer, and the cloud point (CP) of the aqueous polymer solution is measured in a 1 cm quartz cell at 600 nm.
[0052] The surface/interfacial tension of the aqueous solution is tested at room temperature using the BZY-3B automatic meter/interfacial tensiometer.
[0053] Preparation of aqueous solution samples: The graft copolymer sample of various weight is weighed, dissolved in 5 mL of an aqueous solution, and stirred for 12 h to fully dissolve it, so as to prepare the sample to be tested.
Example 1: Synthesis of Fluorine-Containing Alternating Copolymer (AB).SUB.n
[0054] 1,6-Diiodoper-fluorohexane (C.sub.6F.sub.12I.sub.2), sodium ascorbate (AsAc-Na), tris(2,2′-bipyridine)ruthenium dichloride (Ru(bpy).sub.3Cl.sub.2), methanol (1 mL), 1,4-dioxane (3 mL), 1,7-octadiene (C.sub.8H.sub.14) were sequentially added to a 5 mL ampoule in proportion, wherein [C.sub.6F.sub.12I.sub.2].sub.0:[C.sub.8H.sub.14].sub.0:[Ru(bpy).sub.3Cl.sub.2].sub.0:[AsAc-Na].sub.0= 1.2:1:0.02:0.5 (molar ratio), with 0.5 mmol of 1,6-diiodoper-fluorohexane as a reference. After adding a stir bar, three rounds of freezing-evacuating-introducing argon were performed, and the ampoule was flame-sealed. The ampoule was irradiated under blue LED, and stirred at room temperature. At this time, the solution was bright red, reacted for a predetermined time and then removed, upon which the solution was dark brown. The solution was diluted with 1-2 mL of tetrahydrofuran, precipitated in a large amount of methanol in a disposable plastic cup, sealed with a plastic wrap, and then stood overnight in a freezer. The reaction solution was suction filtered under reduced pressure to obtain a purple-black product, which was dissolved in a small amount of tetrahydrofuran, passed through a neutral alumina column to remove metal salts, and precipitated in a large amount of methanol. The precipitate was white. It was allowed to stand overnight in a freezer, and then suction filtered under reduced pressure. The obtained white product was dried in a constant-temperature vacuum oven at 40° C. to a constant weight and weighed. Finally, a fluorine-containing alternating copolymer (AB).sub.n was obtained with a yield of 75%. The structure of the fluorine-containing alternating copolymer (AB).sub.n is shown below:
##STR00009##
where n = 5-10.
[0055] The molecular weight (M.sub.n) and polydispersity index (PDI) of the polymer were measured by gel permeation chromatography (GPC), and the structure was characterized by .sup.1H NMR and .sup.19F NMR. The results are shown in
Example 2: Nucleophilic Substitution of Fluorine-Containing Alternating Copolymer (AB).SUB.n
[0056] Sodium azide was used as the nucleophilic reagent, the phase catalyst was 18-crown-6, and the nucleophilic reaction gave a fluorine-containing alternating copolymer (AB).sub.n-N.sub.3. The reaction route and specific steps were as follows.
##STR00010##
[0057] The fluorine-containing alternating copolymer (AB).sub.n (1.0 eq.) prepared in Example 1, sodium azide (20.0 eq.), 18-crown-6 (40.0 eq.), and chloroform (2.0 mL) were sequentially added to a 5 mL ampoule in proportion. After adding a stir bar, three rounds of freezing-evacuating-introducing argon were performed, and the ampoule was flame-sealed. The ampoule was placed in a heated stirrer at 55° C., stirred, and removed after a predetermined period of time. The ampoule was opened and the solution was diluted with 1 to 2 mL of tetrahydrofuran, which was passed through a neutral alumina column to remove unreacted NaN.sub.3 and precipitated in a large amount of methanol. Then, it was sealed with a plastic wrap, and stood overnight in a freezer. The reaction solution was suction filtered under reduced pressure to obtain a yellowish product. The obtained yellowish product was dried in a low-temperature vacuum temperature to a constant weight and weighed. Finally, the fluorine-containing alternating copolymer (AB).sub.n-N.sub.3 was obtained after nucleophilic substitution.
[0058] The .sup.1H NMR spectra of the polymer before and after nucleophilic substitution are shown in
[0059] The GPC chromatogram of the copolymer before and after nucleophilic substitution are shown in
[0060] The FT- IR spectra of the polymer before and after nucleophilic substitution are shown in
Example 3. Synthesis of Graft Copolymer of Main Chain Type “Semi-Fluorinated” Alternating Copolymer
[0061] The fluorine-containing alternating copolymer (AB).sub.n—N.sub.3 (1.0 eq.) obtained after nucleophilic substitution prepared in Example 2, OMEG having a polyethylene glycol segment and a terminal alkynyl group (20.0 eq.), cuprous bromide (2.0 eq.), pentamethyldiethylenetriamine (PMDETA) (2.0 eq.), and tetrahydrofuran (2.0 mL) were sequentially added to a 5 mL ampoule in proportion. After adding a stir bar, three rounds of freezing-evacuating-introducing argon were performed, and the ampoule was flame-sealed. The ampoule was placed in a heated stirrer at 25° C., stirred, and removed after a predetermined period of time. The ampoule was opened, and the solution was diluted with 1 to 2 mL of tetrahydrofuran, passed through a neutral alumina column to remove the metal salt catalyst, precipitated in a large amount of petroleum ether, sealed with a plastic wrap and then allowed to settle down overnight at room temperature. On the following day, the supernatant was decanted, and the polymer was dried in a constant-temperature vacuum oven at 40° C. to a constant weight and weighed. Finally, the graft copolymer (AB).sub.n-g-OMEGwith main chain type “semi-fluorinated” alternating copolymer backbone was obtained.
[0062] The .sup.1H NMR spectra of the graft copolymers before and after reaction are shown in
[0063] The GPC traces of the graft copolymers (AB).sub.n-g-OMEG before and after reaction are shown in
TABLE-US-00001 “Click” reaction of fluorine-containing alternating copolymer (AB).sub.n-N.sub.3 with OMEG of different chain lengths Entry M .sup.a[(AB).sub.n-N.sub.3I.sub.0:[OMEG].sub.0:[CuBr].sub.0:[PMDETA].sub.0 T (°C) .sup.bM.sub.n,GPC (g/mol) .sup.bM.sub.w/M.sub.n 1 OMEG.sub.3 1:20:2:2 25 9700 1.25 2 OMEG.sub.6 1:20:2:2 25 12600 1.29 3 OMEG.sub.9 1:20:2:2 25 13300 1.22 4 OMEG.sub.22 1:20:2:2 50 21000 1.14
[0064] Reaction conditions: m.sub.(AB)n-N3= 0.1 g, M.sub.(AB).sub.n-N3 = 8400 g/mol, M.sub.w/M.sub.n = 1.25. V.sub.THF = 2 mL, t = 24 h. .sup.aRiato = [(AB).sub.n-N.sub.3].sub.0:[OMEG].sub.0:[CuBr].sub.0:[PMDETA].sub.0. .sup.b Molecular weight and molecular weight distribution measured by GPC (using linear PMMA in THF as standard).
[0065] In this embodiment, the structural formula OMEG is shown below:
##STR00011##
. As shown in Table 1, OMEG.sub.3, OMEG.sub.6, OMEG.sub.9, and OMEG.sub.22 have an m of 3, 6, 9, and 22 respectively. In
[0066] The FT-IR spectra of the graft copolymers (AB).sub.n-g-OMEG before and after reaction are shown in
Example 4. Use of Graft Copolymer of Main Chain Type “Semi-Fluorinated” Alternating Copolymer in the Preparation of Surfactants
[0067] The UV-vis absorption spectra of the aqueous solutions of (AB).sub.n-g-OMEG.sub.6, (AB).sub.n-g-OMEG.sub.9, and (AB).sub.n-g-OMEG.sub.22 prepared in Example 3 are shown in
[0068] The surface tension test results of the aqueous solution of the graft copolymer prepared in Example 3 are shown in
[0069] While preferred embodiments of the present invention have been described above, the present invention is not limited thereto. It should be noted that some improvements and variations can be made by those skilled in the art without departing from the technical principles of the present invention, which are also contemplated in the protection scope of the present invention.